Literature DB >> 30336483

Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis.

Peter M Elias, Joan S Wakefield, Mao-Qiang Man.   

Abstract

We compare here the principal characteristics of over-the-counter moisturizers with physiologic lipid-based barrier repair therapy. Moisturizers are standard ancillary therapy for anti-inflammatory skin disorders, like atopic dermatitis (AD), and can attenuate the emergence of AD, the initial step in the "atopic march." But not all moisturizers are beneficial; some can make skin function worse, and can even induce inflammation, possibly accounting for the frequent occurrence of "sensitive skin" in women. In contrast, physiologic lipid-based barrier repair therapy, if comprised of the 3 key stratum corneum lipids, in sufficient quantities and at an appropriate molar ratio, can correct the barrier abnormality and reduce inflammation in AD, and perhaps in other inflammatory dermatoses.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Antihistamines; Atopic dermatitis; Barrier function; Barrier response; Ceramides; Cytokines; Epidermal lipids; Kallikreins; Moisturizers; PPAR; pH

Mesh:

Substances:

Year:  2018        PMID: 30336483     DOI: 10.1159/000493641

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  10 in total

1.  Pilot study measuring transepidermal water loss (TEWL) in children suggests trilipid cream is more effective than a paraffin-based emollient.

Authors:  Sayantani Sindher; Shifaa S Alkotob; Melanie N Shojinaga; Helen A Brough; Henry T Bahnson; Susan Chan; Gideon Lack; Donald Y M Leung; Kari C Nadeau
Journal:  Allergy       Date:  2020-04-12       Impact factor: 13.146

2.  Increases in plasma IgG4/IgE with trilipid vs paraffin/petrolatum-based emollients for dry skin/eczema.

Authors:  Sayantani Sindher; Shifaa S Alkotob; Melanie N Shojinaga; Robert Hamilton; Susan Chan; Shu Cao; Henry T Bahnson; Helen A Brough; Gideon Lack; Donald Y M Leung; Kari C Nadeau
Journal:  Pediatr Allergy Immunol       Date:  2020-05-06       Impact factor: 6.377

Review 3.  Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence.

Authors:  Adelaide A Hebert; Frank Rippke; Teresa M Weber; Noreen Heer Nicol
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

Review 4.  Breaking the Itch-Scratch Cycle: Topical Options for the Management of Chronic Cutaneous Itch in Atopic Dermatitis.

Authors:  Ian P Harrison; Fabrizio Spada
Journal:  Medicines (Basel)       Date:  2019-07-18

5.  Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-Induced Psoriasis-Like Dermatitis in Mice.

Authors:  Jiun-Wen Guo; Yu-Pin Cheng; Chih-Yi Liu; Haw-Yueh Thong; Chi-Jung Huang; Yang Lo; Chen-Yu Wu; Shiou-Hwa Jee
Journal:  Pharmaceutics       Date:  2020-05-17       Impact factor: 6.321

6.  By protecting against cutaneous inflammation, epidermal pigmentation provided an additional advantage for ancestral humans.

Authors:  Tzu-Kai Lin; Mao-Qiang Man; Katrina Abuabara; Joan S Wakefield; Hamm-Ming Sheu; Jui-Chen Tsai; Chih-Hung Lee; Peter M Elias
Journal:  Evol Appl       Date:  2019-09-24       Impact factor: 5.183

Review 7.  The Role of Sphingolipids in Allergic Disorders.

Authors:  Araceli Díaz-Perales; Maria M Escribese; María Garrido-Arandia; David Obeso; Elena Izquierdo-Alvarez; Jaime Tome-Amat; Domingo Barber
Journal:  Front Allergy       Date:  2021-06-14

Review 8.  Strategies to Develop a Suitable Formulation for Inflammatory Skin Disease Treatment.

Authors:  Jiun-Wen Guo; Shiou-Hwa Jee
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 9.  Xenobiotic Receptors and Their Mates in Atopic Dermatitis.

Authors:  Deborah Minzaghi; Petra Pavel; Sandrine Dubrac
Journal:  Int J Mol Sci       Date:  2019-08-29       Impact factor: 5.923

Review 10.  Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration.

Authors:  Dae Hyun Ha; Hyun-Keun Kim; Joon Lee; Hyuck Hoon Kwon; Gyeong-Hun Park; Steve Hoseong Yang; Jae Yoon Jung; Hosung Choi; Jun Ho Lee; Sumi Sung; Yong Weon Yi; Byong Seung Cho
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.